Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study.
- DOI
- 10.5217/ir.2024.00213
- Published
- 2026 Apr
- Container
- Intestinal research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5217/ir.2024.00213,
title = {Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study.},
author = {Takeuchi K and Nakase H and Hisamatsu T and Matsuoka K and Arai S and Yuasa H and Oe M and Ono R and Keating M and Gu G and Lazin K and McDonnell A and Fukuta K and Hibi T},
year = {2026},
journal = {Intestinal research},
doi = {10.5217/ir.2024.00213},
url = {https://doi.org/10.5217/ir.2024.00213}
}RIS
TY - JOUR TI - Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study. AU - Takeuchi K AU - Nakase H AU - Hisamatsu T AU - Matsuoka K AU - Arai S AU - Yuasa H AU - Oe M AU - Ono R AU - Keating M AU - Gu G AU - Lazin K AU - McDonnell A AU - Fukuta K AU - Hibi T PY - 2026 JO - Intestinal research DO - 10.5217/ir.2024.00213 UR - https://doi.org/10.5217/ir.2024.00213 ER -
APA
K, T., H, N., T, H., K, M., S, A., H, Y., M, O., R, O., M, K., G, G., K, L., A, M., K, F., & T, H. (2026). Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study.. Intestinal research. https://doi.org/10.5217/ir.2024.00213